Adam B. Weiner, MD(@Adam_Weiner535) 's Twitter Profileg
Adam B. Weiner, MD

@Adam_Weiner535

Fellow @UclaUrology @UroOnc ♋️🧬|Supporting editor @EUplatinum📝|Formerly: @NM_Urology @Uchipritzker @Yale ‘12|@abhita_reddy=No one can do it better❤️

ID:23269670

linkhttps://www.ncbi.nlm.nih.gov/myncbi/12AgCapNreHQ4/bibliography/public/ calendar_today08-03-2009 03:12:17

2,7K Tweets

2,3K Followers

1,7K Following

Follow People
Urology Graduate Medical Education at Cedars-Sinai(@UroResidentsCS) 's Twitter Profile Photo

How are docs communicating life expectancy (LE) to patients w/ PCa? John R. Heard, MD, MS Timothy Daskivich study suggests

➡️Significant heterogeneity in communication style

➡️ Non-evidence based calculations of LE

Improvements needed in calculation/communication to avoid over-treatment

How are docs communicating life expectancy (LE) to patients w/ PCa? @john_r_heard @TimDaskivich study suggests ➡️Significant heterogeneity in communication style ➡️ Non-evidence based calculations of LE Improvements needed in calculation/communication to avoid over-treatment
account_circle
Rashid K. Sayyid(@RKSayyid) 's Twitter Profile Photo

EMBARK: Survival outcomes of patients who d/c therapy by 37 weeks
🔷Enza +LHRHa: 90.4% d/c therapy
🔷LHRHa: 67%
🔷Enza mono: 85.6%

Re-started therapy for PSA rise following d/c
🔷Enza +LHRHa: 75%
🔷LHRHa: 84%
🔷Enza mono: 89%

Re-achieve an undetectable PSA response
🔷Enza…

EMBARK: Survival outcomes of patients who d/c therapy by 37 weeks 🔷Enza +LHRHa: 90.4% d/c therapy 🔷LHRHa: 67% 🔷Enza mono: 85.6% Re-started therapy for PSA rise following d/c 🔷Enza +LHRHa: 75% 🔷LHRHa: 84% 🔷Enza mono: 89% Re-achieve an undetectable PSA response 🔷Enza…
account_circle
Andrew J. Hung, MD(@AjhungMD) 's Twitter Profile Photo



🤖 🤖🤖 FIRST EVER ARTIFICIAL INTELLIGENCE SESSION AT Amer. Urol. Assn.

🔆🔆TODAY Friday 9:30-11:30 in 301B 🔆🔆

Moderated by myself, Gene Shkolyar (Stanford), Daniel Lee (UPenn)

Featuring a new interactive format for moderated posters

account_circle
Stephen Freedland, MD(@SFreedlandMD) 's Twitter Profile Photo

Great presentation from our fellow Percy Daniels showing that is linked with larger prostate volume but not change in prostate volume over time.

Great presentation from our fellow Percy Daniels showing that #insulinresistance is linked with larger prostate volume but not change in prostate volume over time. #AUA2024
account_circle
Rachel Mann, MD(@You_the_Mann) 's Twitter Profile Photo

🚨 are you a resident/fellow at ? Come to the resident pavilion (in the exhibitor hall) for some fantastic content at the Resident’s forum! 🚨 Amer. Urol. Assn.

🚨 are you a resident/fellow at #AUA2024? Come to the resident pavilion (in the exhibitor hall) for some fantastic content at the Resident’s forum! 🚨 #urosome #urology #residency @AmerUrological
account_circle
Phillip Pierorazio(@drphil_urology) 's Twitter Profile Photo

This is becoming standard yearly advice for the AUA meeting...

Leave the laptop in your room
Be at the meeting when you are at the meeting
there is so much to enjoy
urology
science
colleagues
friends
learning

if you have to do work, do it, & be present for that too!

account_circle
Laura Bukavina(@LauraBukavinaMD) 's Twitter Profile Photo

Exploring the cancer risks of GLP-1 agonists: Our latest study in European Urology Oncology reveals ⬆️risks of bladder and kidney cancer vs SGLT2 & metformin. Not all GLP-1 usage reduces cancer risk—details on these complex dynamics now authors.elsevier.com/a/1j0yJ9Cfv--d…

Exploring the cancer risks of GLP-1 agonists: Our latest study in @EurUrolOncol reveals ⬆️risks of bladder and kidney cancer vs SGLT2 & metformin. Not all GLP-1 usage reduces cancer risk—details on these complex dynamics now #BladderCancer #CancerResearch authors.elsevier.com/a/1j0yJ9Cfv--d…
account_circle
Adam B. Weiner, MD(@Adam_Weiner535) 's Twitter Profile Photo

🚨Pelvic lymph node XRT improves survival for young men w/ 🚨

Journal of Clinical Oncology ASCO

🗓️Median f/u 10.2 years, n=350

☢️For men <65 years WPRT improved
✅OS: HR 0.33
✅PCSM: HR 0.17

👉Post-hoc analysis of an RCT from 2005!!! Before any PSMA PET…

🚨Pelvic lymph node XRT improves survival for young men w/ #prostatecancer🚨 @JCO_ASCO @ASCO 🗓️Median f/u 10.2 years, n=350 ☢️For men <65 years WPRT improved ✅OS: HR 0.33 ✅PCSM: HR 0.17 👉Post-hoc analysis of an RCT from 2005!!! Before any PSMA PET…
account_circle
Yash Shah(@YashBShah) 's Twitter Profile Photo

Are you a medical student or resident attending ? I’m starting a collaborative thread with advice on how to make the most of the Annual Meeting as a trainee. Everyone is encouraged to reply with your advice below! 🧵

account_circle
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺(@Cacciamani_MD) 's Twitter Profile Photo

Wow! already 110 Registered attendees!!

Make sure not to miss your spot for the inaugural Amer. Urol. Assn. course on Practical !

🤖Surgical AI
🤕Patients AI
🩻Radiology AI
🎓Regulations & Research AI

👉register now tinylink.net/CIcXT

@usc_urology Tao Tu

Wow! already 110 Registered attendees!! Make sure not to miss your spot for the inaugural @AmerUrological #AUA24 course on Practical #AI! 🤖Surgical AI 🤕Patients AI 🩻Radiology AI 🎓Regulations & Research AI 👉register now tinylink.net/CIcXT @usc_urology @taotu831…
account_circle
YUO(@SUO_YUO) 's Twitter Profile Photo

is around the corner! Be sure to add the Society of Urologic Oncology content to your schedules 🗓️

This year’s content will feat. DrBagrodia on Biomarkers in Testis Cancer, Kelly Bree on Updates in Prostate Cancer, SamWashUro on Disseminating Tx to Underserved Pts & many more stars!🌟

#AUA24 is around the corner! Be sure to add the @UroOnc content to your schedules 🗓️ This year’s content will feat. @AdityaBagrodia on Biomarkers in Testis Cancer, @KKBree on Updates in Prostate Cancer, @SamWashUro on Disseminating Tx to Underserved Pts & many more #YUO stars!🌟
account_circle